Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2872 |  OVID Ovid Therapeutics Inc. - Common Stock | 2.71 USD | -3.21% | -3.90% | +15.32% | +146.36% | 529.26 M USD | ||
| 2883 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 10.81 USD | -1.10% | -5.18% | +8.21% | +159.86% | 528.50 M USD | ||
| 2889 |  CABA Cabaletta Bio, Inc. - Common Stock | 3.13 USD | 0.00% | +14.65% | +13.82% | +90.85% | 530.68 M USD | ||
| 2891 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 6.28 USD | -5.28% | +11.94% | +61.86% | +390.63% | 501.17 M USD | ||
| 2899 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.10 USD | -3.80% | -1.82% | +8.58% | +107.69% | 500.93 M USD | ||
| 2900 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 10.78 USD | -3.84% | -7.15% | -15.85% | -43.26% | 499.95 M USD | ||
| 2915 |  EVMN Evommune, Inc. Common Stock | 13.20 USD | -5.58% | -9.71% | +17.75% | -23.79% | 479.06 M USD | ||
| 2928 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.43 USD | -4.32% | -6.93% | -14.31% | +603.17% | 472.55 M USD | ||
| 2930 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.84 USD | -4.00% | -7.25% | +12.61% | +48.26% | 472.42 M USD | ||
| 2934 |  RZLT Rezolute, Inc. - Common Stock | 4.82 USD | -5.30% | +4.56% | -2.63% | -31.14% | 464.13 M USD | ||
| 2944 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.58 USD | -1.86% | +19.70% | +3.27% | -24.04% | 477.67 M USD | ||
| 2947 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.26 USD | -2.01% | +5.47% | +4.28% | +5.71% | 475.38 M USD | ||
| 2956 |  EDIT Editas Medicine, Inc. - Common Stock | 3.05 USD | -1.93% | +8.54% | +15.97% | +8.16% | 468.42 M USD | ||
| 2957 |  PBYI Puma Biotechnology Inc - Common Stock | 9.03 USD | -2.27% | +1.35% | +12.31% | +70.38% | 466.13 M USD | ||
| 2962 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 7.00 USD | -5.28% | +4.79% | -7.53% | -21.17% | 450.38 M USD | ||
| 2970 |  OCGN Ocugen, Inc. - Common Stock | 1.33 USD | -4.32% | -0.75% | +6.40% | +31.68% | 451.02 M USD | ||
| 2983 |  BNTC Benitec Biopharma Inc. - Common Stock | 13.46 USD | -0.15% | +7.51% | +16.03% | -18.96% | 462.41 M USD | ||
| 2991 |  EYPT EyePoint, Inc. - Common Stock | 5.11 USD | -3.95% | +21.96% | -59.05% | -57.42% | 440.54 M USD | ||
| 2999 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 12.91 USD | -2.57% | -3.73% | +2.79% | -12.18% | 441.10 M USD | ||
| 3024 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.30 USD | -2.39% | +3.11% | +11.11% | +65.11% | 425.08 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |